The stock's rise snapped a three-day losing streak.

Health insurance companies Anthem and Cigna have been ordered by the Virginia State Corporation Commission to reimburse hundreds of Virginians who were overcharged.

In a report released today, Jessica Tassan from Piper Sandler maintained a Buy rating on Cigna (CI – Research Report), with a price target of $3 ...

Cigna faces significant risks due to potential healthcare reforms and scrutiny on PBMs, making it a "Hold" until it drops below $230/share. Read my CI stock thesis.

Now that the Medicare Annual Enrollment Period is here, Daniel Strobel, Medicare President for Alabama with Cigna Healthcare, visits Studio 10 to talk about Medicare Advantage plans.

Cigna stock could be set up to generate strong total returns in the next couple of years. Read more about recent earnings from CI.

Cigna aims to manage the GLP-1 spending panic Overall, executives say, sales look stable, and ICHRAs look interesting.

Year-to-date, Cigna share prices are down 10.3% (as of Dec. 10, 4:00 pm ET). But its investors netted big short-term gains after news broke that deal talks were off between Cigna and Humana.

A Cigna-Humana combination would have created a company with a value exceeding $140 billion, based on their market values, but was certain to attract fierce antitrust scrutiny.

Cigna is planning a $10 billion increase in its share repurchase authority, a major stock buyback that will take place instead of an acquisition of Humana.